Skip to main content
. 2021 Mar 9;12(4):593–602. doi: 10.1021/acsmedchemlett.0c00675

Figure 5.

Figure 5

Compound 31 normalizes EEG phentotype in Kcnt1L/L mice without affecting spontaneous locomotor activity. Acute administration of compound 31 (30 mg/kg, SC) decreased interictal spike frequency (A) and decreased mean number of seizures (B) in Kcnt1L/L mice. Compound 31 (10–150 mg/kg) did not affect spontaneous locomotor activity in wildtype CD-1 mice (C). Data are mean ± SEM, n = 4–10; *P < 0.05 vs respective baseline; ***P < 0.0001 vs vehicle.